Safety Needles Market Would Reach US$ 7,765.7 Mn by 2027

The sole purpose of designing safety needles was to avoid needlestick injuries while collecting fluids and delivering drugs to the body. The key players of global market for safety needles are enhancing their product portfolio by focusing on production of innovative needles with safety features. These players include B. Braun Melsungen AG, Novo Nordisk A/S, Medtronic, and Becton, Dickinson and Company. Becton, Dickinson and Company holds its dominance in the overall market with around 50% share, followed by Medtronic and Novo Nordisk AS. Future Market Insights’ recent report profiles Smith Medical and Argon medical Inc. as emerging safety needle manufacturers, while Terumo Medical Corporation and Boston Scientific Inc. are recognised as mid-level players in the global safety needles market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2029 

Rising Focus on Use of Prefilled Syringes Fuelling the Demand

At present, value of the global safety needles market is estimated to be s worth US$ 3,752.2 Mn, and it is estimated to reach US$ 7,765.7 Mn by 2027-end, witnessing a CAGR of 6.9% during this forecast period. The growing focus on utilization of prefilled syringes for treatment of several ailments is fuelling the demand for safety needles across the globe. Factors such as changing lifestyle habits, exposure to hormones and infection by HCV are expected to result in gynaecological cancers. Rising incidence rate of gynaecological cancers, coupled with higher presence of lower-back problems in regions such as the US are driving the demand for spine needles and other types of safety needles.

Trends Observed in the Global Safety Needles Market

Leading companies are participating in campaigns in co-ordination with governments of several economies for raising awareness about unsafe use of reusable needles among patients. Increasing prevalence of HIV & blood-borne diseases, owing to needle injuries, has also urged the companies for development of needles with enhanced safety features.

Key findings from FMI’s Report Include

• Hypodermic needles, as a product, will dominate the market, and is expected to account for 18.1% share during the forecast period. However, biopsy needles are expected to witness fastest revenue growth at 8.6% CAGR.
• Hospital pharmacies are estimated to account for more than half of safety needles being distributed globally, while private clinics are expected to garner over US$ 1,300 Mn through 2027.
• Drug delivery application of safety needles is expected to gain 242 BPS in its market share. In addition, sample collection is projected to create an absolute $ opportunity of around US$ 1,840 Mn in 2017 over 2016.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2029 

APEJ – Fastest-Growing Safety Needles Market in World

Around 24% market share is estimated to be held by Western Europe by the end of 2027, while APEJ is expected to register fastest growth in the global market for safety needles. In contrast, Eastern Europe is poised to depict a sluggish growth during the forecast period, while North America is will remain the outright dominant region in the global market for safety needles.

Varicose Vein Treatment Market To Register A Spectacular Rise US$ 931.4 Mn By 2026

Unattended varicose veins can cause one severe pain through swelling, ulceration, venous eczema, and lipodermatosclerosis. Treating them through appropriate measures becomes quite crucial. One may opt for non-surgical remedies such as sclerotherapy, leg elevation, or alternative invasive techniques such as endovenous laser treatments. Collectively, these therapies can be addressed as varicose vein treatments, medically-practiced in all parts of the world. The demand for such varicose vein treatments is expected to grow in the years to come.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2538 

Future Market Insights recently conducted its forecast study on the global market for varicose vein treatments, estimating the market’s current value at just over US$ 500 Mn. The report, titled “Varicose Vein Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” projects that rising prevalence of obesity will fuel the incidence rate of varicose veins in the world. Occurrence of varicose vein is medically-proven to be higher among obese people. Along with this, the demand for varicose vein treatments is also expected to grow on the account of effectiveness of the treatments, utilisation of user-friendly devices, and growing emphasis of medical practitioners on ensuring patient safety during critical treatment of varicose veins. Towards the end of 2026, the global market for varicose vein treatment will have reached value of US$ 931.4 Mn, registering a robust growth at 6.4% CAGR.

Varicose Vein Treatments: Market Opportunities

Backed with strong clinical evidence, endovenous laser ablation devices are more popular to treat varicose veins. However, compared to other procedures such as foam fillers, vein stripping costs, and blast with electricity, endscopic variceal ligation (EVL) is a costlier treatment alternative. Launch of cost-effective EVL devices will work as a favourable opportunity for new entrants as well as existing players in the market. Decreasing the procedure costs and enhancing the adoption of affordable devices will cumulatively boost the adoption of varicose vein treatments.

Among the wide variety of endovenous laser ablation devices available in the market, some of them may lead to complications such as thrombophlebitis, nerve damage, burns and deep vein thrombosis conditions. There is a potential opportunity for endovenous laser ablation device manufacturers to tap the larger market by offering competitive products that cause lesser complications.

APEJ Varicose Vein Treatment Market to Record Speedy Growth

Apropos the report, more than 40% of the market revenues will remain concentrated in North America, throughout the forecast period. By 2026-end, North America’s varicose vein treatment market will have reached a value of US$ 420 Mn. US-based AngioDynamics, Inc. will be observed as a key player in the market during this period. In terms of revenue growth, the varicose vein treatment market in Asia-Pacific excluding Japan (APEJ) region is projected to be at the forefront. By exhibiting 7% CAGR, the APEJ varicose vein treatment market will witness active participation of Korean medical device manufacturer, Wontech Co., Ltd. Apart from these, Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, Energist Ltd. and intros Medical Laser GmbH are other companies partaking in the growth of global varicose vein treatment market.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2538 

The report further reveals that hospitals and ambulatory surgical centres as end-users will account for larger share of global revenues, while specialised clinics will register fastest revenue growth at 7.2% CAGR. The report also identifies endovenous laser treatment as the dominant varicose vein treatment in the market, procuring revenues worth over US$ 500 Mn by end of 2026.

Europe Hospital Capacity Management Solutions Market Size to Accelerate at a Rapid 5.1% CAGR Through 2027

Adoption of hospital management capacity solutions will grow at 5.1% CAGR through 2027, according to a latest research by Future Market Insights (FMI). Increasing need for enhanced health safety will influence healthcare institutes to adopt IT/HCMS. Furthermore, emphasis on financial and clinical integration will push incorporation of robust IT infrastructures such as PLEXIS.

Adoption of HCMS is also increasing as it enables users to access real-time location services. As healthcare institutes grapple with rising operating costs, HCMS is being looked upon as a next-gen solution that reduces medical and administrative errors. The market will also continue to be influenced by the broader industry-wide push to amalgamate IT with operations.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-eu-3520 

Moreover, political dynamics have impacted the process of demand and supply through implementation of various healthcare related evolutions and reforms such as ‘The Patient Protection and Affordable Care Act’. The Patient Protection and Affordable Care Act mandates various regulations and requirements regarding storing, capturing and sharing data, which will bring fundamental transformation in various healthcare-related operations. In addition, enhanced technology such as wireless communication and easy internet accessibility, incorporated with various healthcare applications will create new opportunities and enable patients to access related information whenever they need it. Such factors are likely to contribute towards growth of the HCMS market.

However, Future Market Insights identifies that security breaches and vulnerabilities associated with IT will continue to hinder its widespread adoption. Imposition of complicated regulations by governments for enhanced quality and services, along with lack of integration with regards to analytical solutions with platforms such as electronic health record (EHR) can also pose challenges to growth of the HCMS market.

By product type, real-time locating system will account for a majority revenue share of the market. This segment accounted for US$ 88.34 Mn in 2016, and is expected to register highest CAGR through 2027. Event-driven solutions segment is expected to exhibit second-highest CAGR of 5.2% over the following decade.

Regional Analysis

U.K., with total revenues to the tune of US$ 50.78 Mn in 2016, is the largest market for hospital capacity management solutions in Europe. It will remain the largest, and the fastest-growing market in Europe, during the forecast period. The HCMS market in Germany is expected to surpass US$ 80 Mn by 2027.

Vendor Insights

Leading players mainly focus on strategies such as expanding their global footprints through collaboration, conferences, product expansions, partnerships and strengthening distribution networks. Demand for applications and systems for new business requirements will intensify partnerships, mergers and acquisitions and consolidations among market players. Vendors are actively entering into partnerships and acquisitions to consolidate their position in the market. Moreover, majority of the stakeholders in healthcare are adopting cloud computing solutions to address security, scalability and availability issues.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-eu-3520 

Key players operating in the Europe HCMS market include Awarepoint Corporation, Allscripts Healthcare Solutions, Inc., Cerner Corporation, McKesson Corporation, Epic Systems Corporation, TeleTracking Technologies, Inc., Central Logic, Sonitor Technologies, Inc., STANLEY Healthcare Solutions Limited and Care Logistics LLC.

North America Medical Carts Market to Exceed US$ 1,720.8 Mn by 2027

The need for streamlining workflow has necessitated the integration of information technology (IT) solutions in healthcare settings. Medical carts manufactured by companies are presently serving the essential purpose of aiding nursing operations in medical facilities. The robust healthcare infrastructure in the US will demand the adoption of advanced medical carts that not only dispense medical instruments & supplies, but also have integrated IT systems. In the years to come, the demand for medical carts in North America will witness steadfast inclination towards IT-integrated medical carts.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-na-3608 

According to Future Market Insights – “North America’s medical carts market is expected to reach US$ 600 Mn value by 2017-end, and will expand at 11.2% CAGR through 2027 to bring in US$ 1,720.8 Mn in revenues.”

Rising focus on point-of-care diagnosis & treatment has led to an increase in the use of mobile computer medical carts. Computer medical carts are used to record and update a patient’s electronic health records (EHR). Increased adoption of Electronic Health Records (EHR) is also observed to be an instrumental factor for growth of North America’s medical carts market. The report, titled “Medical Carts Market – North America Industry Analysis and Opportunity Assessment, 2017-2027,” also projects that manufacturers of medical carts are extending the product line by introducing medical carts with added features. Omnicell, Inc., Herman Miller, Inc., The Harloff Company, Capsa Solutions LLC, Medline Industries, Inc., Armstrong Medical Industries, Inc., AFC Industries, Waterloo Healthcare, TouchPoint Medical, and Ergotron, Inc. are recognised as leading manufacturers of medical carts in North America.

Constructive Prospects for Future of North America’s Medical Carts Market

A lucrative opportunity for such prominent medical device manufacturers towards consolidating their presence in the medical carts market in North America is changing their product line in accordance with shift in technology. Mechanical medical carts are being gradually replaced by new and enhanced technologies such as powered medical devices with battery systems, locking drawers (with negative tilt to facilitate efficient stocking of medication), and automated medicine dispensing systems.

In addition to this, increased focus on acquisitions and collaboration among companies have helped them expand their clinical carts product portfolio and cater to the demand for efficient healthcare systems. This has boosted the need for more effective and advanced medical equipment, devices and procedures. Emerging players must keep in mind that acquisitions over the years have resulted in strengthening the positions of current market leaders.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-na-3608 

Key Highlights of the Report follow,

• In 2017 and beyond, computer medical carts will remain in great demand, procuring close to 40% of the market’s overall revenues towards the end of 2027
• North America’s medical carts market is poised to witness dominance of metal as base material, revenues from which will reflect a CAGR of 12.1%
• Non-powered medical carts will also be top-sellers in the market, while revenues from sales of powered medical carts are anticipated to showcase 12.6% CAGR
• Hospitals will be the largest end-users of medical carts in North America

Teleradiology Market will Net Revenues US$ 5.5 Bn by 2026

According to National Institute of Cancer, 448.7 new cancer cases per 100,000 men and women are diagnosed each year in the US. Taking into account the gravity of such details, the demand for teleradiology is expected to surge not just in the US, but in regions witnessing higher concurrence of cancer. In its latest report, Future Market Insights assesses that the global demand for teleradiology will soar vigorously in the years to come. And, the report projects that largest share of global teleradiology revenues will be emanating from the US alone. The country will not only account for dominance of North America in the global teleradiology market, but by the end of 2026, US teleradiology revenues will have closed in on US$ 5.5 Bn value. During this period, the US teleradiology market is expected to reflect a sizeable gain of 416 BPS, exhibiting a stellar CAGR of 22.3%.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1747 

According to Future Market Insights, the global market for teleradiology is presently valued at US$ 1.9 Bn, and is anticipated to be worth US$ 13.2 Bn by the end of 2026, reflecting a CAGR of 21%. The report, titled “Teleradiology Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” has analysed the global teleradiology market by splitting other parts of the world from the US. Dominance of US on the global teleradiology market is expected to remain throughout the forecast. Teleradiology Solutions, Argus Radiology, USARAD Holdings, Inc., TeleDiagnosys Services Pvt. Ltd., Imaging Advantage, Foundation Radiology Group, Direct Radiology, Imaging On Call, LLC, ONRAD, Inc., Rays (Envision Healthcare Company), StatRad LLC, ARIS Radiology, NightShift Radiology, Mednax, Inc., Alta Vista TeleRadiology, and Quality Nighthawk are US-based companies actively participating in the growth of global teleradiology market.

However, the report also anticipates higher contribution from Europe and the Asia-Pacific excluding Japan (APEJ) region. By the end of 2026, the teleradiology market in Europe will have reached US$ 2.76 Bn in value, while teleradiology revenues accounted the APEJ region will record fastest growth at 24.6% CAGR. European healthcare companies such as Global Diagnostics (Integral Diagnostics), 4ways Healthcare Limited, Medica Group PLC, Teleconsult Europe, and Telemedicine Clinic are also observed as key market players. The report has also profiled companies such as Everlight Radiology, SRL Diagnostics, and Vital Radiology Services, which are based across the APEJ region.

Easy Access to Teleradiology Promoting its Adoption

The report has observed that increasing consumer awareness regarding teleradiology & easy accessibility of this technology are boosting the market’s growth at considerable extent. Due to online availability of the radiology series, diagnostic images of complex problems can be shared between professionals within a medical setting. Moreover, local clinicians or radiologists can get opinions from subspecialists in order to make informed decision. Active participation and initiatives taken by various government and non-profit organizations to spread awareness regarding telemedicine worldwide is also expected to fuel growth of the global teleradiology market.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1747 

Global Teleradiology Market: Key Research Highlights

• A majority of teleradiologists will be preferring CT-scan as the modality for diagnosis, revenues from which are expected to surge at 23.6% CAGR
• MRI scan and ultrasound scans will also be prominent modes of carrying out teleradiological diagnosis
• While hospitals & clinics, collectively, will remain the largest end-users of teleradiology, the demand for such diagnostic technology is expected to gain traction across ambulatory surgical centres (ASCs)
• By 2026-end, ASCs will account for an estimated 30% share of global teleradiology revenues

Compression Garments and Stockings Market will exhibit a 5.2% CAGR By 2027

According to a latest report published by Future Market Insights, by the end of 2027, the global compression garments and stockings market is anticipated to reach US$ 3,541.3 Mn in value, reflecting a moderate growth at 4.9% CAGR. The global market for compression garments and stockings, which is currently valued at a little over US$ 2,100 Mn, will witness a steady growth in terms of volumes over the forecast period from 2017 to 2027. Towards the end of this period, more than 46 million units of compression garments and stockings will be sold across the globe. The report estimates that volume-wise growth of the global compression garments and stockings market will exhibit a 5.2% CAGR, after recording global sales of 26.5 million compression garments & stockings in 2016.

The report, titled “Compression Garments & Stockings Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” has included multiple factors impacting the growth of global compression garments & stockings market during the forecast period. Growing caseload for varicose vein treatments and orthopaedic surgeries is observed as a key driver boosting the sales of compression garments & stockings. Meanwhile, advancements in fabric and garment designer is serving as a blessing in disguise for compression garment & stocking manufacturers. Moreover, rising sports injuries, increase in the number of orthopaedic surgeries, and rapidly growing obese population witnessed in several parts of the world is boosting the global demand for compression therapy products.

The report has also assessed that compression therapy will remain to be recognized as a gold standard for the treatment of lymphedema, chronic venous insufficiency, and deep vein thrombosis during the forecast period. Compression garments and stockings are easy-to-use, safe, and provides effective treatment in a short time span, which will continue fuelling their sales in the long run. Nonetheless, treatment of vascular diseases with compression therapy products is expensive, and demands greater expenditure for routine follow-ups and out-patient monitoring.

Global Compression Garments & Stockings Market – Forecast Highlights: In 2016, more than 90% of the global compression garments and stockings market revenues was accounted by global sales of compression garments

Through 2027, lower compression garments are pegged to remain in great demand, reflecting a volume CAGR of 5.6%

Throughout the forecast period, varicose veins will be observed as the largest application, account for half of global revenues by 2027-end

Wound care application of compression garments and stockings is also expected to gain traction, showcasing a value CAGR of 5.2%

Towards the end of 2027, more than 15 million compression garments and stockings will be distributed across the globe through hospitals

In the due course of this forecast period, online sales will be observed as fastest-growing distribution channels, exhibiting a robust volume CAGR of 6.5%

North America and Western Europe, together, will be at the forefront of expansion of global compression garments and stockings market

While these two regions account for nearly 70% of the market revenues by 2027-end, the compression garments and stockings markets in Latin America and the Asia-Pacific excluding Japan (APEJ) region will register value CAGRs of 5% and 6.2% respectively

Strict Guidelines Limits the Design Space for Potential Conceptual Ideas: Manufacturing medical compression garments require strict guidelines to be followed. Manufacturers are prioritizing optimal therapeutic efficacy, product reliability and best comfort while producing compression garments and stockings. Faulty products and poorly-designed garments & stockings can cause shearing, a potential problem if the patient has weak skin, a venous ulcer or some other wounds. This constraint limits the design space for potential conceptual ideas as patient safety continues to be the most crucial concern and constraint for manufacturers. The report has profiled leading players in the global compression garments and stockings market, which include 3M, BSN Medical, Nouvelle Inc., Medical Z, medi GmbH & Co KG, Covidien Ltd. (a Medtronic PLC. Company), SIGVARIS, Therafirm, Santemol Group Medical, 2XU Pty. Ltd., and Leonisa, Inc.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3644

Obesity Management Market to Grow at a CAGR of 4.9% through 2027

High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking better return on investments. In the long run, risks and limitations posed by the high development costs of obesity drugs are likely to impede the growth of the global obesity management market.

Future Market Insights’ latest publication estimates that the global market for obesity management will showcase an average growth during the forecast period, 2017-2027. In this period, the market is estimated to grow from US$ 641.6 Mn in 2016 to US$ 1,078.9 by 2027-end, representing a value CAGR of 4.9%. Between 2017 and 2027, the global obesity management market is poised to witness an incremental $ opportunity of over US$ 400 Mn.

In addition the high costs for developing obesity management drugs, the market is also expected to witness restraints from poor healthcare infrastructure in emerging markets. Stringent laws imposed upon drug manufacturers are also impacting the market’s growth. These laws are becoming more ambiguous, resulting into a slow-down in drug production. Moreover, studies revealing side effects of obesity management drugs are also causing major disturbance among regulatory bodies and manufacturers. GlaxoSmithKline plc., VIVUS, Inc., Novo Nordisk A/S, Arena Pharmaceuticals, Inc., F. Hoffmann La Roche Ltd., and Orexigen, Therapeutics, Inc. are companies profiled in the report as leading participants of global obesity management market.

A regional analysis of global obesity management market, compiled in the report, projects that North America’s share on global revenues will surpass 33% towards the end of 2027. North America is anticipated to emerge as the largest market for obesity management in the world. Western Europe will also be at the forefront, bringing in an estimated US$ 222 Mn in revenues by 2027-end. Across different regions in the world, a majority of obesity management drugs will be distributed through hospital pharmacies. With more than 50% share in global revenues, hospital pharmacies will remain the largest distribution channel for obesity management drugs throughout the forecast period.

In terms of surgery, the global demand for obesity management drugs is primarily concentrated towards treatments namely, gastric bypass surgery and gastric sleeve surgery. In addition to this, the report also projects that over one-third of global obesity management revenues will be accounted by global sales of liraglutide drugs. Demand for phentermine and topiramate drugs will also gain traction, registering revenue growth at 7% CAGR. Nonetheless, fastest revenue growth will be recorded by global sales of bupropion and naltrexone drugs, revenues from which will surpass US$ 100 Mn by end of 2027.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-587

Western Europe Medical Recruitment Market to Rise US$ 21.2 Bn by 2028

Over the last decade, healthcare and pharmaceutical industries have witnessed growth across various countries of Western Europe. Moreover, healthcare-related research projects in Western Europe would impact the growth of recruitment services across the region. The Western Europe medical recruitment market is estimated to be valued at US$ 21.22 Bn by the end of 2028, expanding at a moderate CAGR of 3.1% during the forecast period 2018-2028.

Increase in healthcare spending, prevalence of chronic diseases, and the growing population-employment ratio are some factors likely to propel the Western Europe medical recruitment market in the coming years. Germany is projected to exhibit relatively high growth over the forecast period. Increasing prevalence of heart-related diseases and presence of a large number of homecare centres are among major factors fuelling the growth of the medical recruitment market in Western Europe.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-we-3675 

Future Market Insights, in its report on the ‘Western Europe Medical Recruitment Market’ has analyzed and investigated various trends and developments shaping the market. The report also assays a holistic view of the current drivers, trends, and opportunities in the medical recruitment market. FMI has also presented an in-depth understanding of financials, key strategies, and developments of various medical recruitment agencies such as Medacs Healthcare, Euromotion Medical, CPL Healthcare, ProClinical Recruitment, TFS Healthcare, EGV Recruiting, and CCM Recruitment. The report also presents a list of recommendations to the stakeholders in the medical recruitment market.

Burgeoning Pharma Industry and Research Activities to Push for Increased Medical Recruitments

Flourishing medicine development coupled with enhanced production, exports and R&D expenditure is likely to play an important role in increasing the demand for medical recruitment services. Moreover, increase in the employment of new workforce in the region is also expected to drive the medical recruitment market in Western Europe. In the past few years, owing to technological advancements, companies and governments are conducting research on innovative technologies. These research activities require technicians, nurses, lab assistants, medical representatives, pharmacists, and physicians, which in turn, would drive the demand for medical recruitment services in Western Europe during the forecast period.

Key Trends Shaping the Future of the Western Europe Medical Recruitment Market Through 2028

• Since medical institutions churn out a large number of healthcare professionals, recruitment agencies and medical establishments are partnering with educational institutions to tap on potential job aspirants and candidates. The nursing/healthcare staff segment is projected to dominate the medical recruitment market with more than 29% value share. Paramedic staff segment would also witness steady growth in the coming years, owing to the increase in in healthcare organization and CROs.
• Recruiting companies are leveraging the giant networks of social media to enhance their recruiting, selection ability and staffing processes. Medical recruitment agencies are using LinkedIn recruiting solutions to explore potential healthcare candidates.
• With the emergence of new HR technologies like application tracking systems and recruitment marketing platforms, medical recruitment agencies are using Big Data and Analytics to find right candidates and improve cultural fit and retention.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-we-3675 

Channel and expansion strategies along with product innovation and partnerships with other healthcare recruitment agencies are among key strategies adopted by major players in this market to boost their sales.

Respiratory Devices Market to Attain a Value of US$ 34.17 Billion by 2027

The global respiratory devices market was valued at nearly US$ 13 billion in 2016. It is projected to grow at 9.2% CAGR during the period 2017-2027 to reach US$ 34.17 billion in revenues.

Demand for respiratory devices will continue to be driven by increasing ageing population and rising prevalence of COPD and obstructive sleep apnea. Increasing emphasis on healthcare spending in developing countries, especially in Asia Pacific and Latin America, will continue to positively influence the growth of the market.

Adoption of non-invasive techniques in pulse oximeters and advancement in full polysomnography testing are also favourably impacting the growth of the market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-794 

Although Future Market Insights maintains a positive outlook on the global respiratory devices market, premium pricing, budgetary constraints, and increasing use of generic product types can impede the growth of the market.

The key trends expected to influence the global respiratory devices market in the foreseeable future are,

• Portable and wearable devices are steadily gaining popularity among patients owing to ease-of-use and flexibility in carrying the devices.
• Growing demand for stationary oxygen concentrator with pulse flow technology and rechargeable batteries.
• Increasing demand for respiratory devices in Asia Pacific on account of rising prevalence of chronic obstructive pulmonary diseases. Multinational companies are focusing on consolidating their position in developing countries to leverage upon the emerging opportunities.

Positive Airway Pressure Devices Account for the Highest Demand

According to Future Market Insights’ research, positive airway pressure devices currently account for the highest demand. This segment accounted for nearly 29% revenue share of the market in 2017; by 2027, this is projected to increase to 34.6%. In terms of revenues, positive airway pressure devices segment is projected to reach US$ 11.81 billion in revenues by 2027.

Other key product types by revenue are respiratory consumables (respiratory masks, nasal cannulas, tracheostomy tubes and oxygen tubes) and pulse oximeters.

Future Market Insights also offers market forecast and analysis on other key respiratory devices, including nebulisers, oxygen concentrators, polysomnography devices, mechanical ventilators, and spirometers.

Hospitals Largest End-users

By end-user, the key segments include hospitals, ambulatory surgical centres, clinics, and long-term care centres. Currently, hospitals account for the highest demand for respiratory devices, followed by ambulatory surgical centres and long-term care centres. Demand for respiratory devices from hospitals was worth US$ 5.18 billion in 2016; by 2027, this is projected to grow at 9.8% CAGR to reach US$ 14.36 billion.

U.S. Continues to Account for Significant Percentage of Global Sales

The U.S. remains the largest market for respiratory devices globally. On the back of strong sales in the U.S., the North America respiratory devices market accounted for over 40% revenue share of the market in 2016. Future Market Insights projects North America to remain the largest market for respiratory devices during the period 2017-2027.

Western Europe and APEJ are the other leading markets for respiratory devices. These two markets collectively accounted for a revenue share of over 35% in 2016.

Future Market Insights, in its report, has also profiled the respiratory devices market in Latin America, Eastern Europe, Japan, and MEA.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-794 

In its report, companies profiled by Future Market Insights are Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc, Hamilton Medical AG, Medtronic PLC, Koninklijke Philips N.V., Smiths Medical, General Electric Healthcare Limited, Drägerwerk AG & Co. and KGaA, Inogen Inc.

Intra-Abdominal Pressure Measurement Devices Market to Witness an Outstanding Growth During 2016 – 2026

According to Future Market Insights’ survey on physician practice pattern concerning intra-abdominal pressure measurement devices, 33.9% physicians admitted to never measuring bladder pressure in the ICU.

(All figures available in the report)

Rising prevalence of intra-abdominal hypertension (IAH), combined with development of DEHP-free products is fuelling demand for intra-abdominal pressure measurement devices. According to a new research by Future Market Insights, the global intra-abdominal pressure measurement devices market will grow at a CAGR of 16.5% to reach US$ 173.3 Mn by 2026.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2612 

The report predicts adoption of intra-abdominal hypertension (IAH) to witness steady adoption in developing countries. Currently, bulk of the demand for these devices is concentrated in America and Europe. Asia Pacific, Latin America, and GCC are among the regions where demand for intra-abdominal pressure measurement devices will grow steadily during the forecast period.

According to Future Market Insights, collaboration between intra-abdominal pressure measurement device manufacturers and catheters for measuring IAP in ICUs is growing. Further, owing to better sensitivity and accuracy of these devices, many physicians are preferring clinical examination of IAH over physical detection.

Use of intra-abdominal pressure measurement devices in abdominal procedures was estimated at 1,472,000 in 2016. Future Market Insights estimates it to reach 7,246,000 by 2026.

North America continued to be the leader in the number of abdominal pressure measurement procedures in 2016. Of the 1,472,000 procedures carried out in 2016, North America accounted for 647,000. It is pertinent to mention that Canada’s share of abdominal procedures was negligible, accounting for only 44,000 procedures in 2016. The U.S. continues to remain the country where a majority of abdominal pressure measurement procedures were conducted in 2016. Western Europe was the second highest region, with 275,000 procedures, whereas Asia Pacific excluding Japan (APEJ) was at third position.

By product type, Future Market Insights offers analysis and forecast on disposables and equipment. According to the study, disposables segment accounted for higher revenue share of the overall market in 2016. Future Market Insights estimates this trend to continue during the forecast period 2016-2026.

By application type, Future Market Insights has segmented the market into intra-compartment pressure and intra-abdominal hypertension. Demand for intra-abdominal pressure measurement devices was higher for intra-abdominal hypertension. This segment was valued at US$ 32.5 Mn in 2016.

By end-user, hospitals accounted for the highest demand for intra-abdominal pressure measurement devices in 2016. Trauma centres, clinics, and ambulatory surgical centres were the key application segments.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2612 

Leading intra-abdominal pressure measurement device manufacturers include C. R. Bard, Inc., Stryker Corporation, Holtech Medical, ConvaTec Group PLC, and Biometrix Ltd. According to the report, C. R. Bard, Inc. accounted for nearly 30% revenue share of the global intra-abdominal pressure measurement devices market. Stryker Corporation and Holtech Medical were the other key players by market share.

Prefilled Formalin Vials Market Value Projected to Expand by 2028

The growth of the healthcare industry is expected to play a vital role in shaping the future prospects of the prefilled formalin vials market. Formalin is a derivative of formaldehyde, and prefilled formalin vials are used for tissue fixation. According to a latest research by Future Market Insights (FMI), the global prefilled formalin vials market is projected to account for over US$ 515.8 Mn, in terms of value, by 2028 end. The report on prefilled formalin vials market projects significant growth potential with average compound annual growth rate pegged at 4.1% through 2028.

Prefilled Formalin Vials Market: Overview

According to the new European rules and guidelines, it is essential to protect the environment and the health of the workers who work in an environment where they are directly exposed to aldehydes. Emission of formalin fumes in pathology labs can lead to serious health hazards. The discharge of these fumes can be avoided by using chemical hoods, particularly in operation theatres, where formalin is mostly used. The need to lower the level of formalin emission has surged the demand for prefilled formalin vials, and the growth of the prefilled formalin vials market. In the medical ambulatories including ambulatory surgical centers where small biopsies are performed, the challenges associated with formalin usage are dealt primarily by using prefilled formalin vials or tubes. Direct exposure to formalin increases the risk of developing cancer. Prefilled formalin vials limit the risk of direct exposure to formalin. This factor, in particular, is likely to play an instrumental role in driving the growth of the prefilled formalin vials market.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7582

The prefilled formalin vials can be used for diversified applications in distinct end-use settings such as forensic labs, CROs, emergency medical services, diagnostic laboratories, and veterinary laboratories, among others. Formalin being a cost-effective method of histopathological diagnosis plays a vital role in the healthcare industry, as it cuts down the unnecessary costs associated with the procedural changes related with the usage of new alternative fixatives. In the European Union (EU) in 2017, 971,000 workers were estimated to be exposed to formaldehyde above the background level. Out of these, 175,380 were registered in Italy. Formaldehyde is commonly known to have acute toxicity, resulting in sensory irritation in the eyes and upper respiratory tract. The demand for formalin from veterinary clinics and forensic laboratories has remained stable, but is likely to decline in the near future. This is primarily to due to strict regulations regarding the usage of formalin across the globe.

Prefilled Formalin Vials Market: Segmental Analysis

Prefilled formalin vials are commercially available in different packaging forms in the global prefilled formalin vials market. Of these, 90 – 500 mL prefilled formalin vials are high in demand in the global prefilled formalin vials market, owing to the fact that there is no alternative fixative validated to be served as formalin replacement. Likewise, the 40 – 60 mL prefilled formalin vials segment is also projected to hold significant revenue share as their adoption is increasing in diagnostic and forensic laboratories. Diagnostic laboratories and CROs performing cancer research and diagnostics are the primary consumers of prefilled formalin vials. According to FMI, the contract research organizations segment accounted for over 28.8% revenue share in the global prefilled formalin vials market in 2017.

Formalin is a cost-effective method of histopathology diagnostic in the West and East Asia, owing to which the demand for prefilled formalin vials has increased in the region. Furthermore, the growing incidence of cancer in Asia Pacific due to changing lifestyle of people is likely to boost the growth of the prefilled formalin vials market in the region. Presence of large number of companies with sole focus on providing high-quality prefilled formalin vials and rising disposable income in Japan are factors expected to surge the demand for prefilled formalin vials in the country.

FMI has segmented the global prefilled formalin vials market based on product type and end users. In terms of revenue, the 90 – 500 mL product type segment in the prefilled formalin vials market is expected to hold significant share over the forecast period. In contrary, the <10 mL product type segment in the prefilled formalin vials market is expected to exhibit limited investment opportunities, in terms of revenue, through 2028.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7582

Prefilled Formalin Vials Market: Key Players

The report tracks some of the key companies operating in the prefilled formalin vials market, such as Diapath S.p.A, Histo- Line Laboratories Srl, Cardinal Health, Inc., Leica Microsystems Sales GmbH (Leica Biosystems Nussloch GmbH), Genta Environmental Ltd., Carl Roth GmbH + Co. KG, Magnacol Ltd., Serosep Limited, Ultident Scientific and Solmedia Limited.

Photorejuvenation Equipment Market: Increased Demand for Minimally Invasive Aesthetic Correction Procedures Fuelling Adoption

Advancements in laser technologies over the years have contributed to various applications of cosmetic treatments, contributing to the growth of the global photorejuvenation equipment market. Rising technological advancements with an increasing number of skin problem are anticipated to increase the adoption of photorejuvenation equipment globally. According to the latest research by the company, the global photorejuvenation equipment market is anticipated to account for over US$ 3,100 Mn, in terms of value, by 2028 end. The report on photorejuvenation equipment is expected to show significant growth potential with an average Y-o-Y growth rate pegged at 6.3% through 2028.

Global Photorejuvenation Equipment Market: Overview & Analysis

Rising incidence of skin problems leads to scarring. Acne causes major physical changes which include permanent scarring. Furthermore, nearly 85% of people aged between 12 and 24 experience acne. The commonly used non-invasive treatment for acne scarring is laser resurfacing. The effectiveness of photorejuvenation equipment are widely accepted in dermatology for the treatment of a variety of cutaneous conditions. Thus, the rising prevalence of such skin problems is triggering the growth of the global photorejuvenation equipment market over the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7559

Manufacturers are adopting strategic approaches in order to increase the product reach in the photorejuvenation equipment market. Increasing demand of photorejuvenation equipment for non-invasive photorejuvenation treatments, with frequent product approvals and advancements in photorejuvenation equipment technology, are further boosting the strategic activities like mergers and collaboration agreements among manufacturers and driving the photorejuvenation equipment market growth. Companies operating in the photorejuvenation equipment market are also continuously focusing on increasing the photorejuvenation equipment reach globally. As a result, they are adopting distribution agreements as an expansion strategy to gain maximum revenue share in the global photorejuvenation equipment market. Furthermore, advancements in laser technologies over the years have contributed to various applications of cosmetic treatments, contributing to the growth of the global photorejuvenation equipment market.

Increasing healthcare spending is an indicator of improvement in the healthcare setting as a whole. Increase in the budget of hospitals would indicate the use of better quality equipment's and thus drive the growth of the global photorejuvenation equipment market. According to the IMF, healthcare spending is expected to increase by over 6% yearly, based on the current GDP forecast.

However, high treatment cost and adverse side effects related to the photorejuvenation equipment may hamper the growth of the global photorejuvenation equipment market. Treatment with photorejuvenation equipment, including surgeries and non-invasive treatments, are associated with high costs making them inaccessible to people in the low middle-income groups. Also, non-invasive treatments with photorejuvenation equipment require a series of sessions to achieve the desired result, which results in a high overall cost of the treatment. Furthermore, the duration of treatment, number of sessions and the cost of treatment depend on the area being treated. These factors are directly responsible for dropping the growth of the global photorejuvenation equipment market.

According to the company, the laser equipment segment accounted for over 75% revenue share in the overall photorejuvenation equipment market in 2017. However, the growing popularity of LED and IPL might limit the segment’s growth in the near future. China photorejuvenation equipment market is expected to be the most lucrative market in the global photorejuvenation equipment market during the forecast period.

The company has segmented the global photorejuvenation equipment market into Intense Pulsed Light (IPL) Equipment, Laser Equipment, and LED Equipment. In terms of revenue, the laser equipment segment in photorejuvenation equipment will hold maximum revenue share over the forecast period.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7559

The company’s report tracks some of the key companies operating in the photorejuvenation equipment market, such as Hologic Inc. (Cynosure, Inc.), Lumenis, Syneron Medical Ltd., Lynton Lasers Ltd, EL.EN. S.p.A. (Deka Mela S.r.l.), Fotona, Cutera, Inc., Lutronic Corporation, Beijing Nubway S & T Co., Ltd, and others.

Next Generation Optical Biometry Devices Market Poised to Reach US$ 450 Mn by 2028

Increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals globally are factors increasing the adoption of next generation optical biometry devices. With the advancement in the technology, next generation optical biometry devices have been developed aiding measurement of eyes before cataract and refractive surgeries. Earlier measurement by ultrasound technique was gold standard. However, unlike next generation optical biometry devices, ultrasound devices require direct contact of the probe, which lead to many eye infections.

The next generation optical biometry devices are automated and measure many parameters such as the axial length, anterior chamber depth, thickness of the lens, retinal thickness, pupil size and many more. The next generation optical biometry devices are an accurate alternative for the precise measurements and provide efficient results. Also the next generation optical biometry devices avoid the operator variations measurements.  Research indicates next generation optical biometry devices market is anticipated to account for revenues over US$ 450 Mn, by 2028 end. The report on next generation optical biometry devices projects market revenues to expand at a CAGR of 5.1% through 2028.

According to Prevent Blindness organization, ~25 Mn Americans having cataract require medical care every year in the U.S., hence boosting demand for next generation optical biometry devices. Similar rising demand for next generation optical biometry devices is noted in UK with rising number of cataract surgeries. Increased demand for next generation optical biometry devices is noted in developing markets concurrent with access to eye care facilities. Next generation optical biometry devices are all-in one devices used for evaluation of lens and refraction, of retina.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7556

Next Generation Optical Biometry Devices Market: Overview & Analysis

Rapid increase in number of probe infections due to usage of ultrasound devices, lead to post-operative errors fuelling demand for next generation optical biometry devices instead of ultrasound biometry devices. Manufacturers of next generation optical biometry devices are introducing automated devices which are more efficient in measuring segments of eyes. Players in next generation optical biometry devices market are working on strengthening the software, which could provide detailed information about eye segments. New next generation optical biometry devices introduced are taking into account irregularities and astigmatisms of the anterior and the posterior surfaces of the eye. The next generation optical biometry devices uses a partially coherent wave that has approximately 9x the resolution of a 10 MHz sound wave, for precise measurement of axial length.

Hospitals end users segment account for 41.8% revenue share in the global Next Generation Optical biometry Devices market. Medical services and vision benefits offered under Medicare includes cataract surgeries; which will increase the demand of next generation optical biometry devices.

Increasing geriatric population and rising income in Japan is expected to surge the demand for more advanced Next Generation Optical biometry Devices. Japan Next Generation Optical biometry Devices market is estimated to create absolute $ opportunity worth approximately US$ 1.21 Mn between 2017 and 2028.

The company has segmented the global Next Generation Optical Biometry Devices Market into product type and end users. In terms of revenue, the swept source segment in product type in next generation optical biometry devices market report will account for significant revenue share over the forecast period. In contrary, the Partial coherence interferometry (PCI) based next generation optical biometry devices segment in all the markets will exhibit limited investment opportunities through 2028 in next generation optical biometry devices market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7556

Next Generation Optical Biometry Devices Market: Key Players

The next generation optical biometry devices market report tracks some of the key companies, such as Carl Zeiss AG, Nidek Co Ltd, Haag-Streit AG(Metall Zug AG), Ziemer Ophthalmic Systems, Optovue, Incorporated, Topcon Corporation, TOMEY GmbH,  Movu Inc. (unit of Santec Corporation) , Newway Technology and  OCULUS Optikgeräte GmbH. The largest player in the next generation optical biometry devices market is Carl Zeiss AG with its IOL masters and Haag-Streit AG’s Lenstar.